Cross-border capital continues to flow into complex health technologies as UAE-headquartered diversified business group Crescent Enterprises steps up its investment in surgical automation. The firm has co-led a $30 million Series C funding round in XCath, a Texas-based medical device developer specializing in neuro-endovascular surgical robotics.
Quick Facts
- UAE’s Crescent Enterprises co-led the $30 million Series C.
- XCath has now raised $92 million in total capital.
- Funding supports R&D for neuro-endovascular robotic systems.
Advancing Neuro-Endovascular Surgical Robotics
Founded in 2017 as a spinout from the University of Texas’ Microsurgical Robotics Laboratory, XCath focuses on developing robotic systems that assist physicians during highly delicate procedures inside blood vessels. The technology targets neuro-endovascular interventions, a complex medical field that requires extreme precision when navigating intricate vascular structures.
By introducing robotic assistance to these procedures, the company aims to improve surgical accuracy and minimize risks for patients undergoing critical treatments.
The newly secured capital will directly support ongoing research and development as XCath moves its robotic systems closer to clinical use and broader adoption across the medical sector.
Strategic Backing from MENA and Medtech Veterans
Crescent Enterprises is not a new backer in this venture. The UAE-based group already held an existing stake in the medical robotics company before stepping up to co-lead the Series C alongside Dr. Fred Moll, the chairman of XCath’s board of directors.
This continued financial commitment highlights the growing appetite among MENA investors for deep tech and specialized healthcare hardware that addresses global medical challenges.
About XCath
XCath is a Texas-based medical device company developing neuro-endovascular surgical robotics. Founded as a spinout from the University of Texas, the company builds robotic systems designed to assist physicians in performing highly precise and delicate procedures within complex vascular structures.
About Crescent Enterprises
Crescent Enterprises is a UAE-headquartered diversified business group operating across multiple global sectors. The firm actively invests in emerging technologies, healthcare, infrastructure, and venture capital, supporting growth-stage companies worldwide.
Source: Entarabi
